VIA
CXM

Vantage Investment Advisors’s CARDIUM THERAPEUTICS INC NEW CXM Stock Holding History

Vantage Investment Advisors’s Portfolio CXM Stock Details CXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,350
Closed -$1K – 725
2013
Q4 		$1K Buy
+1,350
New +$1.09K ﹤0.01% 639

Vantage Investment Advisors's CXM Position: Q1 2014 in Review

Vantage Investment Advisors sold out of CARDIUM THERAPEUTICS INC NEW (CXM) in Q1 2014, closing a stake of 1,350 shares — an estimated $1K sold.

Vantage Investment Advisors first reported a position in CXM in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 0 funds tracked by Wall St. Rank hold CXM as of Q1 2014.

  • Vantage Investment Advisors reported no remaining CARDIUM THERAPEUTICS INC NEW position as of Q1 2014 after selling out during the quarter.
  • Vantage Investment Advisors sold 1,350 CARDIUM THERAPEUTICS INC NEW shares in Q1 2014, an estimated $1K.
  • Vantage Investment Advisors first reported a position in CARDIUM THERAPEUTICS INC NEW in Q4 2013 and held it in 1 quarter.
  • Vantage Investment Advisors's CARDIUM THERAPEUTICS INC NEW position peaked at $1K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held CARDIUM THERAPEUTICS INC NEW as of Q1 2014.

Based on Vantage Investment Advisors's 13F filing for Q1 2014, filed 1 May 2014.